Factors Influencing Loss to Follow-Up in HIV Patients: a Retrospective Study
Downloads
Background: HIV has become a global health problem, causing millions of deaths since its discovery. The success of antiretroviral therapy (ART) depends heavily on patient adherence, yet the lost-to-follow-up (LTFU) rate remains high. Purpose: This study aims to identify the characteristics of HIV patients experiencing LTFU and analyze the influencing factors at the Karang Panjang Community Health Center in Ambon City. Methods: This study employs a cross-sectional design with secondary data analysis from theedical records of HIV patients from 2018 to 2024. The sampling technique used was total sampling, with a total sample size of 152 patients. Data analysis was conducted descriptively and inferentially using the chi-square and Fisher’s exact test. Result: The prevalence of LTFU among HIV/AIDS patients at the Karang Panjang Community Health Center is 15.1%. Most LTFU patients are female, over 30 years old, and married. Statistical tests show significant associations between LTFU and age (p = 0.0468), sex (p = 0.0433), and marital status (p = 0.0355), while education and religion are not significant. Among LTFU cases, 8.3% had died, 50% were alive but had stopped therapy, and 41.7% were untraceable. Additional contributing factors identified through discussions and medical record reviews include inadequate counseling and education, poor documentation of ARV side effects, limited financial resources, and insufficient peer or family support. Conclusion: The study concludes that age, sex, and marital status contribute to LTFU among HIV patients. It recommends improving ART retention through education, stricter monitoring, and community-based strategies to reduce future LTFU rates.
Swinkels HM, Justiz Vaillant AA, Nguyen AD, et al. HIV and AIDS. [Updated 2024 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534860/
Waymack JR, Sundareshan V. Acquired Immune Deficiency Syndrome. [Updated 2023 May 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537293/
Cardenas MC, Farnan S, Hamel BL, Mejia Plazas MC, Sintim-Aboagye E, Littlefield DR, et al. Prevention of the vertical transmission of HIV: a recap of the journey so far. Viruses 2023;15(4):849.
World Health Organization. HIV statistics, globally and by WHO region, 2024.
Liu AY, Buchbinder SP. CROI 2024: global epidemiology and prevention of HIV and other sexually transmitted diseases. Top Antivir Med 2024;32(3):447-82.
Kementerian Kesehatan Republik Indonesia. Laporan penilaian risiko cepat Mpox di Indonesia tahun 2024. 2024.
Dinas Komunikasi dan Persandian Kota Ambon. Statistik sektoral Kota Ambon tahun 2024. Pemerintah Kota Ambon; 2024.
Kilkoda F, Balqis, Indar, Darmawansyah, Wahyu A, Daud A, et al. Analysis of factors affecting the utilization of antiretroviral treatment services in HIV patients in Ambon City Puskesmas. Pharmacogn J 2023;15(2):424-8.
Fibriansari RD, Cahyadi AH. Lost to follow up antiretroviral therapy in people with HIV/AIDS at Lumajang. J Pikes 2021;2(1):1-8.
Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. N Am J Med Sci 2014;6(9):453-9.
Data rekam medik pasien HIV Puskesmas Karang Panjang non publikasi. 2018–2024.
Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, et al. Status of HIV-infected patients classified as lost to follow-up from a large antiretroviral program in southwest Nigeria. PLoS One 2019;14(7):e0219903.
Zhou J, Tanuma J, Chaiwarith R, Lee CKC, Law MG, Kumarasamy N, et al. Lost to follow-up in HIV-infected patients from the Asia-Pacific region: results from TAHOD. AIDS and Treatment 2012;2012:1–10.
Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdottir TB, Richter C, et al. Prediktor dan korelasi kepatuhan terhadap terapi antiretroviral (ART) kombinasi untuk infeksi HIV kronis: meta-analisis. BMC Med 2014;12:142.
Bygrave H, Kranzer K, Hilderbrand K, Whittall J, Jouquet G, Goemaere E, et al. Trends in lost to follow-up among migrant workers on antiretroviral therapy in a community cohort. PLoS One 2020;5(10):1–5.
Buju RT, Akilimali PZ, Kamangu EN, Mesia GK, Kayembe JMN, Situakibanza HN. Incidence and predictors of loss to follow up among patients living with HIV under dolutegravir in Bunia, Democratic Republic of Congo: a prospective cohort study. Int J Environ Res Public Health 2022;19(8).
Guajardo E, Giordano TP, Westbrook RA, Black WC, Njue-Marendes S, Dang BN. The effect of initial patient experiences and life stressors on predicting lost to follow-up in patients new to an HIV clinic. AIDS Behav 2022;26(6):1880–91.
Xie J, Gu J, Chen X, Liu C, Zhong H, Du P, et al. Baseline and process factors of anti-retroviral therapy that predict loss to follow-up among people living with HIV/AIDS in China: a retrospective cohort study. AIDS Behav 2022;26(4):1126–37.
Alvarez-Uria G, Naik PK, Pakam R, Midde M. Faktor-faktor yang berhubungan dengan putus sekolah, kematian, dan kehilangan tindak lanjut setelah dimulainya terapi antiretroviral: data dari studi kohort HIV di India. Glob Health Action 2013;6:21682.
Oluoch T, Cornet R, Muthusi J, Katana A, Kimanga D, Kwaro D, et al. A clinical decision support system is associated with reduced loss to follow-up among patients receiving HIV treatment in Kenya: a cluster randomized trial. BMC Med Inform Decis Mak 2021;21(1):357.
Aulia U, Andriani NK, Irwan I. Faktor yang mempengaruhi lost to follow-up pasien HIV-AIDS dengan terapi ARV pada kelompok LSL. Preventive 2024;15(1):94-114.
Copyright (c) 2025 Berkala Ilmu Kesehatan Kulit dan Kelamin

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.















